datametrix AG, Faubourg de l’Hôpital, 3, 2000 Neuchâtel, Switzerland
+41 (0)32 511 4575

dare to share initiative the AZ BioVentureHub: real-word data analytics and their growing use in life sciences

Dates: March 25, 2021 Location: virtual From understanding the patient journey to supporting the clinical development to understanding the current market for treatment options, there is a growing use of real-world data analytics. This development is driven by an increasing abundance of medical data on the one hand, and a clear call from Regulators to make better use of that data on the other. Another reason why increasingly we may turn to real world data research to advance biopharma business deliverables, is the current pandemic. It is having a clear impact on clinical research, global study activity dropping by as much as 60%1) In this webinar, datametrix presented several different real-world data analytics use cases, and engaged with the participants in

Personal Data Protection Statement

The information you provide allows us to provide you with information and updates on datametrix’s services (the purpose). By submitting your details in this form, you give explicit consent that your personal details may be used for this and only this purpose by datametrix.

Datametrix, as the data controller and processor, will maintain the data for as long as the data is required for the purposes mentioned above, or until you withdraw consent as stated below. Personal data are not kept longer than necessary and are processed in a manner that ensures appropriate security and confidentiality, including for preventing unauthorized access to or use of personal data and the equipment used for the processing.

We will not sell or give away any personal information that you provide and only use it for the purposes stated above. You may request to view, correct, or delete your data in Clinerion’s database or withdraw consent by contacting info@datametrix.ch. Please note that withdrawal of consent shall not affect the lawfulness of Clinerion’s use of your personal data for the purposes mentioned above before withdrawal of consent.

The legal address of datametrix: datametrix AG, Faubourg de l’Hôpital, 3, 2000 Neuchâtel, Switzerland. e-Mail address info@datametrix.ch.

discussing what suits their own business needs. 1) https://www.fiercebiotech.com/cro/cancer-trials-a-major-victim-pandemic-as-global-studies-dropped-by-60-jama-study

Please fill in the form below to access the meeting slides.

Speakers

This image has an empty alt attribute; its file name is LeonVanWouwe.pngLeon Van Wouwe, Clinical Operations & BD 
Léon is a versatile clinical operations leader with broad experience across a wide range of TA’s (including oncology and autoimune diseases). He has a strong cross functional focus and deep understanding of project functional requirements of organisations. He has worked in a variety of organisations, including large, midsize and small biotech and also in the health technology space.
Léon likes to build the bridges for wellbeing, between biotech, health tech, clinical researchers, clinicians and patients.
This image has an empty alt attribute; its file name is Ahmed_Datametrix2.pngAhmed El Rhali, CEO
 
Ahmed El Rhali is an expert in Data Science, Clinical Trials and Biotechnology. Since 2015 he is President and CEO of datametrix AG, supporting companies in generating the information they need, for making better and faster decisions driving business and clinical benefits and results.
With extensive knowledge and experience in those fields thanks to the numerous years he spent working in senior positions (MD, VP) for large pharma organizations and CRO’s, Ahmed knows your challenges as a decision maker and knows the importance of data to help taking the best, most informed decisions, accelerate timelines and save money to a business unit and even to your organization as a whole.

    Your registration details:

    Comments (optional)